Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Strategies for Constructing Tissue-Engineered Fat for Soft Tissue Regeneration.

Zhao J., Lu F., Dong Z.

Narrative Review on Chronic Wound, published in Tissue Eng Regen Med (2023) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Tissue Eng Regen Med (2023)
Country
Korea (South)
Reported sample size
—
Source database
PubMed
PMID
38032533
PMCID
PMC10987464
DOI
10.1007/s13770-023-00607-z
Citations
1

Abstract (original English)

Background Repairing soft tissue defects caused by inflammation, tumors, and trauma remains a major challenge for surgeons. Adipose tissue engineering (ATE) provides a promising way to solve this problem. Methods This review summarizes the current ATE strategies for soft tissue reconstruction, and introduces potential construction methods for ATE. Results Scaffold-based and scaffold-free strategies are the two main approaches in ATE. Although several of these methods have been effective clinically, both scaffold-based and scaffold-free strategies have limitations. The third strategy is a synergistic tissue engineering strategy and combines the advantages of scaffold-based and scaffold-free strategies. Conclusion Personalized construction, stable survival of reconstructed tissues and functional recovery of organs are future goals of building tissue-engineered fat for ATE.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Tissue EngineeringTissue ScaffoldsAdipose TissueWound HealingCells, Cultured

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research